Deliver
8 known investors
Find your way into Deliver
Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
Investors · 8
Deep Science VenturesLondon
CIVreportedVenice Beach
Costanoa VenturesreportedSan Francisco · $500K – $8M
ForgePoint CapitalreportedSan Mateo · $5M – $50M
Moment Ventures, LlcreportedPalo Alto
Ridge VenturesreportedSan Francisco · $2M – $7M
Zero Infinity PartnersreportedNew York · $100K – $5M
ZIPreportedNew York
In the news
Frequently asked questions
- What does Deliver do?
- Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells in patients for cell and gene therapies, targeting cancer immunotherapies as the first indication with applications in autoimmune, neurodegenerative, and cardiovascular diseases.
- Who are Deliver's investors?
- Deliver's investors include Deep Science Ventures, CIV, Costanoa Ventures, ForgePoint Capital, Moment Ventures, Llc, Ridge Ventures, Zero Infinity Partners, ZIP.





